Published in J Exp Med on October 01, 1986
Evidence that the T cell repertoire of normal rats contains cells with the potential to cause diabetes. Characterization of the CD4+ T cell subset that inhibits this autoimmune potential. J Exp Med (1993) 3.10
Pancreatic islet-specific T-cell clones from nonobese diabetic mice. Proc Natl Acad Sci U S A (1989) 2.12
Requirement for CD8+ T cells in the development of airway hyperresponsiveness in a marine model of airway sensitization. J Exp Med (1996) 1.49
Interstitial nephritis induced by protein-overload proteinuria. Am J Pathol (1989) 1.44
In vivo treatment with monoclonal antibody 3.2.3 selectively eliminates natural killer cells in rats. J Exp Med (1990) 1.10
Role of macrophages in the pathogenesis of encephalomyocarditis virus-induced diabetes in mice. J Virol (1990) 1.00
Experimental studies of immunologically mediated enteropathy. II. Role of natural killer cells in the intestinal phase of murine graft-versus-host reaction. Immunology (1987) 1.00
T cell dysfunction in the diabetes-prone BB rat. A role for thymic migrants that are not T cell precursors. J Exp Med (1988) 0.99
A relationship between proteinuria and acute tubulointerstitial disease in rats with experimental nephrotic syndrome. Am J Pathol (1991) 0.97
Depletion of OX-8 lymphocytes from the blood and airways using monoclonal antibodies enhances the late airway response in rats. J Clin Invest (1993) 0.94
In vivo treatment with a monoclonal antibody to T helper cells in experimental autoimmune glomerulonephritis in the BN rat. Clin Exp Immunol (1994) 0.94
Prevention of diabetes in BB/Wor rats by intrathymic islet injection. J Clin Invest (1992) 0.92
Cytotoxic T-cell precursors with low-level CD8 in the diabetes-prone Biobreeding rat: implications for generation of an autoimmune T-cell repertoire. Proc Natl Acad Sci U S A (1990) 0.92
T cell requirements for the rejection of renal allografts bearing an isolated class I MHC disparity. J Exp Med (1990) 0.88
Effect of CD8+ T-cell depletion on bronchial hyper-responsiveness and inflammation in sensitized and allergen-exposed Brown-Norway rats. Immunology (1999) 0.85
Identification of T cell subsets and class I and class II antigen expression in islet grafts and pancreatic islets of diabetic BioBreeding/Worcester rats. Am J Pathol (1988) 0.84
Immunopathology of diabetes in the RT6-depleted diabetes-resistant BB/Wor rat. Am J Pathol (1990) 0.83
A major histocompatibility complex class II restriction for BioBreeding/Worcester diabetes-inducing T cells. J Exp Med (1995) 0.82
A spontaneous animal model of intestinal dysmotility evoked by inflammatory nitrergic dysfunction. PLoS One (2014) 0.81
Identification of a limited T-cell receptor beta chain variable region repertoire associated with diabetes in the BB rat. Proc Natl Acad Sci U S A (1991) 0.80
Depletion of RT6.1+ T lymphocytes alone is insufficient to induce diabetes in diabetes-resistant BB/Wor rats. Am J Pathol (1990) 0.79
Anti-CD2 monoclonal antibodies prevent spontaneous and adoptive transfer of diabetes in the BB/Wor rat. Am J Pathol (1992) 0.78
Gamma interferon prevents diabetes in the BB rat. Clin Diagn Lab Immunol (1997) 0.78
Exogenously-induced, natural killer cell-mediated neuronal killing: a novel pathogenetic mechanism. J Exp Med (1992) 0.77
Major histocompatibility complex gene product expression on pancreatic beta cells in acutely diabetic BB rats. Am J Pathol (1988) 0.76
Development of the Nonobese Diabetic Mouse and Contribution of Animal Models for Understanding Type 1 Diabetes. Pancreas (2017) 0.75
Abnormal TNF production in prediabetic BB rats is linked to defective CD45R expression. Immunology (1992) 0.75
High stimulatory activity of dendritic cells from diabetes-prone BioBreeding/Worcester rats exposed to macrophage-derived factors. J Clin Invest (1993) 0.75
Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo. Nature (1985) 9.62
Two subsets of rat T lymphocytes defined with monoclonal antibodies. Eur J Immunol (1980) 5.98
The "Ly-1 B" cell subpopulation in normal immunodefective, and autoimmune mice. J Exp Med (1983) 5.74
Successful treatment of autoimmunity in NZB/NZW F1 mice with monoclonal antibody to L3T4. J Exp Med (1985) 3.56
Authentic T helper CD4 (W3/25) antigen on rat peritoneal macrophages. J Exp Med (1985) 3.16
The spontaneously diabetic Wistar rat. Metabolic and morphologic studies. Diabetes (1977) 2.70
Reversal of experimental allergic encephalomyelitis with monoclonal antibody to a T-cell subset marker. Science (1985) 2.68
Natural killer (NK) cell activity in the rat. I. Isolation and characterization of the effector cells. J Immunol (1981) 2.12
Spontaneous diabetes mellitus: reversal and prevention in the BB/W rat with antiserum to rat lymphocytes. Science (1979) 1.87
Passive transfer of diabetes in the BB/W rat. Science (1983) 1.72
Blastogenesis of natural killer cells during viral infection in vivo. J Immunol (1982) 1.72
Adoptive transfer of autoimmune diabetes mellitus in biobreeding/Worcester (BB/W) inbred and hybrid rats. J Immunol (1985) 1.60
The BB diabetic rat. Profound T-cell lymphocytopenia. Diabetes (1981) 1.55
Cyclosporin prevents diabetes in BB Wistar rats. Lancet (1983) 1.50
Spontaneous diabetes mellitus syndrome in the rat. I. Association with the major histocompatibility complex. J Exp Med (1981) 1.49
Experimental allergic encephalomyelitis: successful treatment in vivo with a monoclonal antibody that recognizes T helper cells. J Immunol (1984) 1.46
Neonatal thymectomy prevents spontaneous diabetes mellitus in the BB/W rat. Science (1982) 1.46
MRC OX-52: a rat T-cell antigen. Immunology (1986) 1.43
Transfusions of whole blood prevent spontaneous diabetes mellitus in the BB/W rat. Science (1983) 1.29
Lymphopenia and abnormal lymphocyte subsets in the "BB" rat: relationship to the diabetic syndrome. Endocrinology (1982) 1.28
Deficiency of phenotypic cytotoxic-suppressor T lymphocytes in the BB/W rat. J Immunol (1986) 1.23
Lymphocytic thyroiditis and diabetes in the BB/W rat. A new model of autoimmune endocrinopathy. Diabetes (1981) 1.22
The onset and progression of pancreatic insulitis in the overt, spontaneously diabetic, young adult BB rat studied by pancreatic biopsy. Diabetes (1984) 1.18
Spontaneous diabetes mellitus in the BB/W rat. Effects of glucocorticoids, cyclosporin-A, and antiserum to rat lymphocytes. Diabetes (1983) 1.17
Spontaneous diabetes in rats: destruction of islets is prevented by immunological tolerance. Science (1981) 1.16
Analytical and functional studies on the T cells of untreated and immunologically tolerant diabetes-prone BB rats. J Immunol (1983) 1.15
Genetic analysis of the BB/W diabetic rat. Can J Genet Cytol (1983) 1.14
Dynamic time course studies of the spontaneously diabetic BB Wistar rat. III. Light-microscopic and ultrastructural observations of pancreatic islets of Langerhans. Am J Pathol (1982) 1.10
Autoantibodies in the BB/W rat. Diabetes (1982) 1.09
Total lymphoid irradiation prevents diabetes mellitus in the Bio-Breeding/Worcester (BB/W) rat. Diabetes (1984) 1.08
Islet cell surface antibodies and lymphocyte antibodies in the spontaneously diabetic BB Wistar rat. Diabetes (1982) 1.07
Separation and isolation of rat natural killer (NK) cells from T cells with monoclonal antibodies. J Immunol (1984) 1.06
Prevention of diabetes in rats by bone marrow transplantation. Ann Surg (1981) 1.05
In vivo prevention of thyroid and pancreatic autoimmunity in the BB rat by antibody to class II major histocompatibility complex gene products. Proc Natl Acad Sci U S A (1985) 1.04
Prevention of diabetes mellitus in the BB/W rat with Cyclosporin-A. Am J Pathol (1984) 1.04
Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor. Study of Lck- and FynT-dependent T cell activation. J Biol Chem (1996) 10.08
Streptozotocin-induced pancreatic insulitis: new model of diabetes mellitus. Science (1976) 4.08
A transplantable insulinoma in the rat. Proc Natl Acad Sci U S A (1977) 3.70
Requirement for natural killer cell-produced interferon gamma in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration. J Exp Med (1995) 3.40
Characterization of early IL-12, IFN-alphabeta, and TNF effects on antiviral state and NK cell responses during murine cytomegalovirus infection. J Immunol (1996) 3.30
The role of adrenocorticoids as modulators of immune function in health and disease: neural, endocrine and immune interactions. Brain Res Brain Res Rev (1997) 3.23
An absolute and restricted requirement for IL-12 in natural killer cell IFN-gamma production and antiviral defense. Studies of natural killer and T cell responses in contrasting viral infections. J Immunol (1996) 3.09
Two roads diverged: interferon alpha/beta- and interleukin 12-mediated pathways in promoting T cell interferon gamma responses during viral infection. J Exp Med (1999) 2.98
SAP controls T cell responses to virus and terminal differentiation of TH2 cells. Nat Immunol (2001) 2.95
Pathogen-specific loss of host resistance in mice lacking the IFN-gamma-inducible gene IGTP. Proc Natl Acad Sci U S A (2000) 2.80
Interferon alpha/beta-mediated inhibition and promotion of interferon gamma: STAT1 resolves a paradox. Nat Immunol (2000) 2.75
The spontaneously diabetic Wistar rat. Metabolic and morphologic studies. Diabetes (1977) 2.70
Interferon-alpha/beta inhibition of interleukin 12 and interferon-gamma production in vitro and endogenously during viral infection. Proc Natl Acad Sci U S A (1997) 2.46
Alpha/beta interferon protects adult mice from fatal Sindbis virus infection and is an important determinant of cell and tissue tropism. J Virol (2000) 2.41
Early murine cytomegalovirus (MCMV) infection induces liver natural killer (NK) cell inflammation and protection through macrophage inflammatory protein 1alpha (MIP-1alpha)-dependent pathways. J Exp Med (1998) 2.34
Effects of IL-12 on the response and susceptibility to experimental viral infections. J Immunol (1994) 2.31
Characterization of early cytokine responses and an interleukin (IL)-6-dependent pathway of endogenous glucocorticoid induction during murine cytomegalovirus infection. J Exp Med (1997) 2.14
A chemokine-to-cytokine-to-chemokine cascade critical in antiviral defense. J Clin Invest (2000) 1.97
Studies of streptozotocin-induced insulitis and diabetes. Proc Natl Acad Sci U S A (1977) 1.94
Spontaneous diabetes mellitus: reversal and prevention in the BB/W rat with antiserum to rat lymphocytes. Science (1979) 1.87
Endogenous IL-2 contributes to T cell expansion and IFN-gamma production during lymphocytic choriomeningitis virus infection. J Immunol (1995) 1.84
Immunology of insulin-dependent diabetes mellitus. Annu Rev Immunol (1985) 1.84
Mechanism of interleukin 12-mediated toxicities during experimental viral infections: role of tumor necrosis factor and glucocorticoids. J Exp Med (1995) 1.80
The spontaneously diabetic Wistar rat (the "BB" rat). Studies prior to and during development of the overt syndrome. Diabetologia (1978) 1.79
Blastogenesis of natural killer cells during viral infection in vivo. J Immunol (1982) 1.72
Ultramicro method for determination of glycogen and glucose by enzymic labeling with adenosine triphosphate-gamma-32P. Anal Biochem (1969) 1.66
Increase in NK cell number and turnover rate during acute viral infection. J Immunol (1983) 1.65
Cutting edge: selective IL-18 requirements for induction of compartmental IFN-gamma responses during viral infection. J Immunol (2000) 1.63
Adoptive transfer of autoimmune diabetes mellitus in biobreeding/Worcester (BB/W) inbred and hybrid rats. J Immunol (1985) 1.60
Infection of neonatal mice with sindbis virus results in a systemic inflammatory response syndrome. J Virol (1999) 1.56
Embryogenesis of the human pancreatic islets: a light and electron microscopic study. Diabetes (1972) 1.55
Mapping of a major genetic modifier of embryonic lethality in TGF beta 1 knockout mice. Nat Genet (1997) 1.51
Neonatal thymectomy prevents spontaneous diabetes mellitus in the BB/W rat. Science (1982) 1.46
Complete protection from low-dose streptozotocin-induced diabetes in mice. Nature (1978) 1.45
Replication of murine cytomegalovirus in differentiated macrophages as a determinant of viral pathogenesis. J Virol (1999) 1.42
NK cell functions restrain T cell responses during viral infections. Eur J Immunol (2001) 1.41
Synergism for cytokine-mediated disease during concurrent endotoxin and viral challenges: roles for NK and T cell IFN-gamma production. J Immunol (1999) 1.39
CD4+ and CD8+ T cell interactions in IFN-gamma and IL-4 responses to viral infections: requirements for IL-2. J Immunol (1998) 1.38
Monolayer cell culture of neonatal rat pancreas: an ultrastructural and biochemical study of functioning endocrine cells. J Ultrastruct Res (1973) 1.38
Induction of type I diabetes by Kilham's rat virus in diabetes-resistant BB/Wor rats. Science (1991) 1.37
Increased H2O2, vascular endothelial growth factor and receptors in the retina of the BBZ/Wor diabetic rat. Free Radic Biol Med (2000) 1.36
NK cell trafficking and cytokine expression in splenic compartments after IFN induction and viral infection. J Immunol (1996) 1.35
Elevated natural killer cell-mediated cytotoxicity, plasma interferon, and tumor cell rejection in mice persistently infected with lymphocytic choriomeningitis virus. J Immunol (1983) 1.35
Studies in the diabetic mutant mouse. VI. Evolution of glomerular lesions and associated proteinuria. Am J Pathol (1972) 1.35
Generation of large granular T lymphocytes in vivo during viral infection. J Immunol (1986) 1.33
Susceptibility to diabetes is widely distributed in normal class IIu haplotype rats. Diabetologia (2000) 1.31
The ultrastructure of the secretory cells of the islets of Langerhans in man. Lab Invest (1967) 1.30
Interferon induces natural killer cell blastogenesis in vivo. J Leukoc Biol (1984) 1.30
Transfusions of whole blood prevent spontaneous diabetes mellitus in the BB/W rat. Science (1983) 1.29
Endogenous glucocorticoids protect against cytokine-mediated lethality during viral infection. J Immunol (1999) 1.26
The role of CD4+ cells in sustaining lymphocyte proliferation during lymphocytic choriomeningitis virus infection. J Immunol (1991) 1.26
Increased NADH oxidase activity in the retina of the BBZ/Wor diabetic rat. Free Radic Biol Med (1998) 1.25
Compartmental differences in NK cell responsiveness to IL-12 during lymphocytic choriomeningitis virus infection. J Immunol (2000) 1.25
Deficiency of phenotypic cytotoxic-suppressor T lymphocytes in the BB/W rat. J Immunol (1986) 1.23
Lymphocytic thyroiditis and diabetes in the BB/W rat. A new model of autoimmune endocrinopathy. Diabetes (1981) 1.22
Streptozotocin-induced pancreatic insulitis in mice. Morphologic and physiologic studies. Lab Invest (1978) 1.21
Pancreatic beta cell toxicity by streptozotocin anomers. Diabetes (1977) 1.20
A role for transforming growth factor-beta 1 in regulating natural killer cell and T lymphocyte proliferative responses during acute infection with lymphocytic choriomeningitis virus. J Immunol (1991) 1.19
Diabetic BioBreeding/Worcester (BB/Wor) rats need not be lymphopenic. J Immunol (1986) 1.19
Murine natural killer cells stimulated in vivo do not express the T cell receptor alpha, beta, gamma, T3 delta, or T3 epsilon genes. J Immunol (1987) 1.18
Spontaneous diabetes mellitus in the BB/W rat. Effects of glucocorticoids, cyclosporin-A, and antiserum to rat lymphocytes. Diabetes (1983) 1.17
Interferon beta in multiple sclerosis: is IL-12 suppression the key? Immunol Today (2000) 1.17
Genetic influence of the streptozotocin-induced insulitis and hyperglycemia. Diabetes (1977) 1.16
Studies on streptozotocin diabetes. Diabetes (1976) 1.16
Spontaneous autoimmune diabetes mellitus in the BB rat. Diabetes (1982) 1.15
Genetic analysis of the BB/W diabetic rat. Can J Genet Cytol (1983) 1.14
The activation of IL-2 transcription in L3T4+ and Lyt-2+ lymphocytes during virus infection in vivo. J Immunol (1989) 1.14
Studies in the diabetic mutant mouse. I. Light microscopy and radioautography of pancreatic islets. Diabetologia (1970) 1.13
Mechanisms for virus-induced liver disease: tumor necrosis factor-mediated pathology independent of natural killer and T cells during murine cytomegalovirus infection. J Virol (1997) 1.09
Autoantibodies in the BB/W rat. Diabetes (1982) 1.09
Studies in the diabetic mutant mouse. II. Electron microscopy of pancreatic islets. Diabetologia (1970) 1.09
Total lymphoid irradiation prevents diabetes mellitus in the Bio-Breeding/Worcester (BB/W) rat. Diabetes (1984) 1.08
Influence of environmental viral agents on frequency and tempo of diabetes mellitus in BB/Wor rats. Diabetes (1991) 1.07
Lymphocyte transfusions prevent diabetes in the Bio-Breeding/Worcester rat. J Clin Invest (1984) 1.07
Insulin and glucagon release from monolayer cell cultures of pancreas from newborn rats. Eur J Clin Invest (1973) 1.07
Genetics of the BB rat: association of autoimmune disorders (diabetes, insulitis, and thyroiditis) with lymphopenia and major histocompatibility complex class II. Endocrinology (1995) 1.06
Studies in the diabetic mutant mouse. 3. Physiological factors associated with alterations in beta cell proliferation. Diabetologia (1970) 1.05
Potential pathways for regulation of NK and T cell responses: differential X-linked lymphoproliferative syndrome gene product SAP interactions with SLAM and 2B4. Int Immunol (2000) 1.05
IFN induction and associated changes in splenic leukocyte distribution. J Immunol (1993) 1.04
Prevention of diabetes mellitus in the BB/W rat with Cyclosporin-A. Am J Pathol (1984) 1.04
Activation and role of natural killer cells in virus infections. Med Microbiol Immunol (1982) 1.04
IL-2-dependent NK cell responses discovered in virus-infected beta 2-microglobulin-deficient mice. J Immunol (1994) 1.03
Transforming growth factor-beta expression and natural killer cell responses during virus infection of normal, nude, and SCID mice. J Immunol (1993) 1.02
Spontaneous diabetes in the gnotobiotic BB/W rat. Diabetes (1979) 1.01
Immune attack on pancreatic islet transplants in the spontaneously diabetic BioBreeding/Worcester (BB/W) rat is not MHC restricted. J Immunol (1985) 1.00
Spontaneous autoimmune diabetes mellitus in the BioBreeding/Worcester rat. Surv Synth Pathol Res (1984) 0.99
Infection of peripancreatic lymph nodes but not islets precedes Kilham rat virus-induced diabetes in BB/Wor rats. J Virol (1993) 0.99
Sex differences in the multiple-dose streptozotocin model of diabetes. Endocrinology (1978) 0.98
Natural killer cell development is blocked in the context of aberrant T lymphocyte ontogeny. Int Immunol (1996) 0.97
Effects of cyclosporin A on IL-2 production and lymphocyte proliferation during infection of mice with lymphocytic choriomeningitis virus. J Immunol (1990) 0.96
A hybird artifical pancreas. Trans Am Soc Artif Intern Organs (1975) 0.95